ZTS NYSE
Zoetis Inc.
1W: -2.3%
1M: +9.5%
3M: +0.3%
YTD: -37.6%
1Y: -46.2%
3Y: -52.0%
5Y: -60.2%
$78.23
-2.74 (-3.38%)
Weekly Expected Move ±3.6%
$75
$78
$81
$84
$87
Credit Risk of going bust: lower than 57% of companies Debt: 22.2% of company value Bonds: $301.2M held by 308 funds, 68 bp over Treasuries → details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $1.76 (down 98%), Zoetis Inc. would be worth roughly what it owes.
Total debt $9.24B against a stock market value of $32.33B.
Distance to default 5.81 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $4.52B (short-term plus half of long-term), stock volatility 40.4%; Altman Z 4.73. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
If the stock fell to about $1.76 (down 98%), Zoetis Inc. would be worth roughly what it owes.
Total debt $9.24B against a stock market value of $32.33B.
Distance to default 5.81 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $4.52B (short-term plus half of long-term), stock volatility 40.4%; Altman Z 4.73. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
2 relationships0
As Filer
counterparties named
2
As Counterparty
mentioned by others
2024-04-29
Earliest Filing
2024-10-31
Latest Filing
Mentioned As Counterparty
2 mentionsOther companies that named ZTS in their SEC 8-K filings.
| Filed By | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|
| PAHC PHIBRO ANIMAL HEALTH CORP | acquirer | Target of the $350 million cash acquisition for medicated feed additive and water soluble products portfolio. | 2024-10-31 | View |
| PAHC PHIBRO ANIMAL HEALTH CORP | acquirer | Target of acquisition for medicated feed additive product portfolio and related assets | 2024-04-29 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-10-13 | Officer/Director Change; Regulation FD; Exhibits | View | |
| 2026-10-08 | Regulation FD; Exhibits | View | |
| 2026-08-06 | Earnings Release; Exhibits | View | |
| 2026-08-06 | Officer/Director Change; Exhibits | View | |
| 2026-05-22 | Officer/Director Change; Shareholder Vote | View | |
| 2026-05-20 | Regulation FD; Exhibits | View | |
| 2026-05-07 | Earnings Release; Exhibits | View | |
| 2026-02-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-02-05 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-12-18 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale | Agreement | View |
| 2025-12-11 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-12-02 | Other Events; Financial Statements and Exhibits | View | |
| 2025-11-04 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-10-28 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2025-10-09 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-08-27 | Entry into Material Definitive Agreement; Termination of Material Definitive Agreement; Creation of | Agreement | View |
| 2025-08-18 | Other Events; Financial Statements and Exhibits | View | |
| 2025-08-05 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-05-22 | Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit | View | |
| 2025-05-21 | Regulation FD Disclosure; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR